- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PD-L1 (programmed cell death ligand 1)
Total 93748 results
-
Merck Sharp & Dohme LLCCompletedNon-Small Cell Lung CancerUnited States, Canada, Hungary, Israel, Spain
-
Lene Meldgaard KnudsenCompleted
-
Case Comprehensive Cancer CenterCompletedMetastatic Renal Cell CancerUnited States
-
Naestved HospitalRecruitingNon-small Cell Lung Cancer | Malignant Pleural EffusionDenmark
-
Merck Sharp & Dohme LLCActive, not recruitingHepatocellular CarcinomaUnited States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Denmark, France, Germany, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Malaysia, New Zealand, Norway, Poland, Russian Federation, Spai... and more
-
Merck Sharp & Dohme LLCCompletedEsophageal NeoplasmsTaiwan, China, United States, Argentina, Australia, Brazil, Canada, Chile, Colombia, Costa Rica, Denmark, France, Germany, Guatemala, Hong Kong, Japan, Korea, Republic of, Malaysia, Peru, Romania, Russian Federation, South Africa, S... and more
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdSunshine Lake Pharma Co., Ltd.Terminated
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Squamous CellUkraine, United States, Argentina, Australia, Brazil, Canada, Chile, Colombia, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Mexico, New Zealand, Norway, Poland, Portugal, Romania, Russian Federation, Spain, United Kingdom
-
Incyte CorporationWithdrawn
-
Cancer Research UKHeptares Therapeutics LimitedRecruitingSarcoma | Neoplasms | Kidney Neoplasms | Uterine Cervical Neoplasms | Stomach Neoplasms | Head and Neck Neoplasms | Lung Neoplasms | Urinary Bladder Neoplasms | Colorectal Neoplasms | Pancreatic Neoplasms | Esophageal Neoplasms | Mesothelioma, Malignant | Prostatic Neoplasms, Castration-Resistant | PheochromocytomasUnited Kingdom
-
Hunan Cancer HospitalXiangya Hospital of Central South University; Innovent Biologics (Suzhou) Co...UnknownSmall Cell Lung Carcinoma | Small-cell Lung Cancer | Small Cell Lung Cancer Extensive Stage | Small Cell Lung Cancer RecurrentChina
-
Merck Sharp & Dohme LLCActive, not recruitingClassical Hodgkin LymphomaPoland, United States, Australia, Canada, Chile, France, Israel, Italy, Russian Federation, Spain, Turkey
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced Solid TumorsChina
-
Merck Sharp & Dohme LLCWithdrawn
-
Hunan Province Tumor HospitalCompleted
-
Merck Sharp & Dohme LLCCompletedGastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma
-
Merck Sharp & Dohme LLCActive, not recruitingNon-Small Cell Lung CancerPoland, United States, Brazil, France, Guatemala, Hungary, Japan, Korea, Republic of, Peru, Romania, Russian Federation, South Africa, Spain, Taiwan, Turkey, Ukraine
-
Merck Sharp & Dohme LLCCompletedRichter Syndrome | Mediastinal Large B-cell Lymphoma
-
Merck Sharp & Dohme LLCCompletedEsophageal Carcinoma | Esophagogastric Junction Carcinoma
-
University of LeipzigRecruitingHepatocellular CarcinomaGermany
-
Merck Sharp & Dohme LLCTerminatedAdvanced/Metastatic MelanomaUnited States, Australia, Chile, France, Germany, Israel, Italy, Korea, Republic of, Norway, South Africa, Spain
-
Sun Yat-sen UniversityRecruitingColorectal Cancer Stage IV | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)China
-
Qilu Hospital of Shandong UniversityWithdrawn
-
Checkpoint Therapeutics, Inc.Novotech (Australia) Pty LimitedRecruitingMelanoma | Renal Cell Carcinoma | Head and Neck Cancer | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Non Hodgkin Lymphoma | Endometrial Cancer | Carcinoma, Small Cell | Urothelial Carcinoma | Classical Hodgkin Lymphoma | Merkel Cell Carcinoma | Cutaneous Squamous Cell Carcinoma | Malignant Mesothelioma, AdvancedAustralia, New Zealand, Thailand, Ukraine, Spain, Russian Federation, France, Poland, South Africa
-
Merck Sharp & Dohme LLCRecruiting
-
Merck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast NeoplasmsColombia, United States, Canada, Chile, France, Germany, Hungary, Ireland, Japan, Korea, Republic of, Poland, Spain, Taiwan, Ukraine, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-Small-Cell LungPoland, United States, Hungary, Israel, Italy, Korea, Republic of, Spain
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-Small-Cell LungPoland, United States, Hungary, Israel, Italy, Korea, Republic of, Spain
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingCarcinoma, HepatocellularUnited States, Australia, Canada, Chile, China, Colombia, France, Germany, Ireland, Italy, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Russian Federation, Spain, Taiwan, Thailand, Turkey, United Kingdom
-
Sarah GoldbergMirati Therapeutics Inc.TerminatedLung Diseases | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Metastatic Lung Non-Small Cell Carcinoma | PD-L1 Gene Mutation | Pembrolizumab | Stage IV Lung Non-Small Cell Cancer AJCC v7 | Advanced Treatment-Naïve PD-L1 | SitravatinibUnited States
-
Junling LiRecruitingAdvanced Non Squamous NSCLCChina
-
Ludwig Institute for Cancer ResearchAstraZenecaCompletedEsophageal CancerUnited Kingdom
-
NYU Langone HealthBristol-Myers SquibbCompleted
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UMC UtrechtCompletedEsophageal Cancer, Stage II | Esophageal Cancer Stage IIINetherlands
-
Consorzio OncotechActive, not recruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | PD-L1 Gene MutationItaly
-
BeiGeneRecruitingNon-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Spain, France, Malaysia, Italy, Canada, Thailand, Georgia, Brazil, Korea, Republic of, Singapore, Moldova, Republic of, Romania
-
Merck Sharp & Dohme LLCCompletedSmall Cell Lung Cancer (SCLC)United States, Australia, Canada, Chile, France, Germany, Hungary, Ireland, Israel, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Switzerland, Taiwan, Turkey, United Kingdom
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRecruiting
-
Merck Sharp & Dohme LLCEuropean Organisation for Research and Treatment of CancerActive, not recruiting
-
AkesoAkeso Pharmaceuticals, Inc.CompletedMelanoma | Advanced Solid TumorsChina
-
Poitiers University HospitalActive, not recruitingNon Small Cell Lung Cancer | Gene Mutation-Related Cancer | PD-L1 | PET/CTFrance
-
Fondazione Ricerca TraslazionaleUnknownTo Define an Easy and Feasible Panel Which May be Routinely Applied to Select Patients for Immunotherapy Avoiding More Complex and Expensive Methods
-
Merck Sharp & Dohme LLCRecruitingAdvanced Solid Tumors | Metastatic Solid TumorsCanada, Switzerland, United States
-
IO BiotechMerck Sharp & Dohme LLCCompletedNSCLCUnited Kingdom, Germany, Netherlands, Spain
-
TransgenePfizer; EMD Serono Research & Development Institute, Inc.; Merck KGaA, Darmstadt...Active, not recruitingHPV-Related Carcinoma | HPV-Related Cervical Carcinoma | HPV-Related Anal Squamous Cell Carcinoma | HPV-Related Penile Squamous Cell Carcinoma | HPV-Related Vulvar Squamous Cell CarcinomaUnited States, France, Spain
-
Pharmassist LtdUniversity of AthensActive, not recruitingMelanoma | Non Small Cell Lung Cancer | Head and Neck Squamous Cell CarcinomaGreece
-
Peking University Cancer Hospital & InstituteRecruitingMelanoma | Lung Cancer | PD-L1 | PET/CTChina
-
Hutchison Medipharma LimitedRecruitingExtensive-Stage Small Cell Lung CancerChina
-
National Institute for Tuberculosis and Lung Diseases...SuspendedInterstitial Lung Disease | Lung Neoplasm MalignantPoland